Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Oxford Instruments Turns To Profit In FY10 - Update

June 15th, 2010

Oxford Instruments Turns To Profit In FY10 - Update

Abstract:
High-tech tools manufacturer Oxford Instruments Plc (OXIG.L) Tuesday announced preliminary results for fiscal 2010, reporting a profit for the year, compared with a loss last year. The turnaround reflects improved revenues, lower reorganization and impairment charges, and a one-time mark to market gain on derivative financial instruments.

For fiscal 2010, the Abingdon, Oxfordshire-based company's profit before taxation was GBP 18.1 million as compared with a loss of GBP 9.3 million in the prior-year period. On an adjusted basis, pre-tax profit rose 7.2% to GBP 11.9 million from GBP 11.1 million in fiscal 2009.

Source:
stockmarketsreview.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers demonstrates substrate design principles for scalable superconducting quantum materials: NYU Tandon–Brookhaven National Laboratory study shows that crystalline hafnium oxide substrates offer guidelines for stabilizing the superconducting phase October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025

Announcements

Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project